named programs · 2 · from sources
What they call their work
Daily Briefing on Addiction and Substance Use
Provides evidence-based analysis and updates on national trends in addiction, including opioid use, youth vaping, marijuana legalization, and psychedelic therapies.
Policy and Research Synthesis
Produces summaries and critiques of scientific studies and policy developments related to addiction treatment, drug regulation, and public health impacts.
activities · 3 groups
What they do
-
Substance Use Policy Advocacy & Public Education 3 activities
- Advocate for drug policy reformProduces public commentaries and advocates for progressive drug policy changes, including marijuana legalization, psilocybin decriminalization, and comprehensive responses to the overdose epidemic through expanded treatment access and improved care systems.
- Conduct research on substance use and public policyConducts and publishes research on the risks of high-potency marijuana, prescription opioids, and psychedelics; evaluates treatment approaches such as psilocybin for treatment-resistant depression; and analyzes state-level policy developments including marijuana legalization, flavored tobacco bans, and voter trends in drug policy reform.
- Produce and distribute the Daily Briefing podcastProduces and distributes a regular podcast providing updates and analysis on addiction-related topics for public and professional audiences.
-
-
Employment Support for Recovery 1 activity
- Develop addiction treatment programs through partnershipsPartnered with Belden, Inc. in 2018 to create the Pathways to Employment drug treatment program, integrating recovery support with workforce development.
-
-
Substance Use Information and Referral Services 1 activity
- Provide addiction information resourcesProvides information and educational resources on addiction to individuals, families, healthcare professionals, and policymakers to support treatment and policy decisions.
-
financials · form 990EZ · fy2023
revenue
Total revenue$10K
Contributions & grants$10K100%
Program service revenue——
Investment income——
Other revenue—
expenses
Total expenses$7K
Program expenses78%
Admin / overhead4%
Fundraising18%
Salaries & benefits—
Grants paid out—
Largest expense lineCompensation
balance sheet
Total assets$107K
Cash$87K
Investments$368K
Liabilities$56K
Net assets$107K
Liquid reserves771.5 mo
4 years on record · 2019–2023 · YoY revenue -98.9%
leadership · form 990 part vii · fy2023
Who runs it
board members · 5
- Chip Fisher — Director
- Douglas Schoen — Director
- Jenna Levine — Director
- Shirley Lord Rosenthal — Director
- Steve Ivy — Director
relationships · 9
Who they work with
- American Psychiatric Association Government — Opposes psilocybin legalization initiative, citing lack of scientific evidence and public health concerns.
- Belden, Inc. Partner — Partnered with the Rosenthal Center to create the Pathways to Employment drug treatment program.
- PayPal Funder — Platform used for receiving donations.
- Pew Trust Partner — Source of data and analysis on marijuana decriminalization trends cited in reporting.
- Phoenix House Partner — Collaborative relationship through shared leadership and legacy; founder of Rosenthal Center was also founder of Phoenix House.
- Phoenix House Partner — Founded by Dr. Rosenthal as a network of drug treatment centers, indicating a foundational and ongoing organizational relationship.
- Phoenix House Foundation Network — Founded within the Phoenix House Foundation in 2007.
- STAT News Partner — Collaborates on dissemination of research findings through media publication.
- Treatment Communities of America Network — Organizational affiliation; Mitchell S. Rosenthal was part of TCA from its beginning.
strategies · 5
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Compassionate, Individual-Centered Care Modelmethodology: compassionate_careBy providing unconditional and accessible services regardless of background or condition, the organization fosters trust and engagement, because compassion and dignity remove psychosocial barriers to treatment and recovery.
- Information Dissemination to Improve Access and Practicesmethodology: information_disseminationBy disseminating research-based information to affected individuals, treatment professionals, and policymakers, the organization improves access to services and enhances treatment practices, because informed stakeholders make better decisions and systems become more responsive.
- Integrated Public Health Approach to Addictionmethodology: integrated_public_healthBy combining harm reduction, decriminalization, and expanded treatment access, the organization addresses addiction as a public health issue rather than a criminal one, because this integrated model reduces stigma, increases engagement in care, and improves population-level outcomes.
- Perception-Shaping Through Research and Media Engagementmethodology: perception_shapingBy using research, convenings, and media outreach to correct misinformed perceptions about drug use and recovery, the organization influences public behavior and policy, because public understanding shapes both individual choices and legislative responses.
- Regulatory Public Health Advocacymethodology: regulatory_public_healthBy advocating for evidence-based regulation—such as THC dosing caps and state-controlled psilocybin administration—the organization reduces public health risks associated with high-potency substances, because regulated access prevents commercial overuse and ensures therapeutic integrity.